Podcast with CEO Tord Labuda
Date: 2025-04-30
In the latest episode of Småbolagspodden, CEO Tord Labuda shares insights into Alzinova’s work in developing a vaccine for Alzheimer’s disease.
The conversation covers the technology behind ALZ-101, the recently completed Phase 1b study, and the potential advantages of a vaccine-based approach in treating Alzheimer’s.
Listen to the podcast below, in Swedish.